ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Aventis Pharma Limited

Aventis Pharma Limited is an active company incorporated on 18 December 1980 with the registered office located in Reading, Berkshire. Aventis Pharma Limited was registered 44 years ago.
Status
Active
Active since 24 years ago
Company No
01535640
Private limited company
Age
44 years
Incorporated 18 December 1980
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Over 250 employees
Confirmation
Submitted
Dated 22 December 2024 (9 months ago)
Next confirmation dated 22 December 2025
Due by 5 January 2026 (2 months remaining)
Last change occurred 4 years ago
Accounts
Submitted
For period 1 Jan31 Dec 2023 (12 months)
Accounts type is Full
Next accounts for period 31 December 2024
Due by 31 December 2025 (2 months remaining)
Address
410 Thames Valley Park Drive
Reading
Berkshire
RG6 1PT
England
Same address for the past 6 years
Telephone
01142843200
Email
Available in Endole App
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Managing Director • British • Lives in UK • Born in Dec 1978
Director • Accountant • British • Lives in UK • Born in Jun 1979
Sanofi-Aventis UK Holdings Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Fisons Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
Sanofi-Synthelabo UK Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
Rhone-Poulenc Rorer Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
May & Baker Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
Sanofi-Aventis UK Holdings Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
RPR (Us) Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
Aventis Pharma Holdings Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
Genzyme Therapeutics Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2014–2023)
Period Ended
31 Dec 2023
For period 31 Dec31 Dec 2023
Traded for 12 months
Cash in Bank
£144K
Increased by £46K (+47%)
Turnover
£397.78M
Decreased by £20.02M (-5%)
Employees
666
Decreased by 27 (-4%)
Total Assets
£2.27B
Increased by £258.87M (+13%)
Total Liabilities
-£745.46M
Increased by £225.75M (+43%)
Net Assets
£1.53B
Increased by £33.13M (+2%)
Debt Ratio (%)
33%
Increased by 6.99% (+27%)
Latest Activity
Rippon Ubhi Details Changed
5 Months Ago on 14 May 2025
Confirmation Submitted
8 Months Ago on 9 Feb 2025
Full Accounts Submitted
1 Year 2 Months Ago on 15 Jul 2024
Rippon Ubhi Appointed
1 Year 7 Months Ago on 1 Mar 2024
Jessamy Rachel Baird Resigned
1 Year 7 Months Ago on 1 Mar 2024
Confirmation Submitted
1 Year 8 Months Ago on 25 Jan 2024
Full Accounts Submitted
1 Year 11 Months Ago on 25 Oct 2023
Confirmation Submitted
2 Years 9 Months Ago on 6 Jan 2023
Full Accounts Submitted
3 Years Ago on 7 Oct 2022
Confirmation Submitted
3 Years Ago on 7 Feb 2022
Get Credit Report
Discover Aventis Pharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Second filing for the appointment of Rippondeep Ubhi as a director
Submitted on 27 May 2025
Director's details changed for Rippon Ubhi on 14 May 2025
Submitted on 19 May 2025
Confirmation statement made on 22 December 2024 with no updates
Submitted on 9 Feb 2025
Full accounts made up to 31 December 2023
Submitted on 15 Jul 2024
Appointment of Rippon Ubhi as a director on 1 March 2024
Submitted on 3 Mar 2024
Termination of appointment of Jessamy Rachel Baird as a director on 1 March 2024
Submitted on 1 Mar 2024
Confirmation statement made on 22 December 2023 with no updates
Submitted on 25 Jan 2024
Full accounts made up to 31 December 2022
Submitted on 25 Oct 2023
Confirmation statement made on 22 December 2022 with no updates
Submitted on 6 Jan 2023
Full accounts made up to 31 December 2021
Submitted on 7 Oct 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year